STOCKS | Novo Nordisk Seeks Preliminary Injunction Against Eli Lilly GLP-1 Ads
2026-07-24 08:36:12
According to Jin10, Novo Nordisk (NVO.N) said it filed a motion for a preliminary injunction in the U.S. District Court in New Jersey, seeking an immediate halt to Eli Lilly's (LLY.N) misleading GLP-1 advertising campaign while its lawsuit continues.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
